130 related articles for article (PubMed ID: 14695997)
1. Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children.
Liberzon E; Avigad S; Stark B; Zilberstein J; Freedman L; Gorfine M; Gavriel H; Cohen IJ; Goshen Y; Yaniv I; Zaizov R
Genes Chromosomes Cancer; 2004 Feb; 39(2):161-6. PubMed ID: 14695997
[TBL] [Abstract][Full Text] [Related]
2. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
[TBL] [Abstract][Full Text] [Related]
4. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
5. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
Cavaciuti E; Laugé A; Janin N; Ossian K; Hall J; Stoppa-Lyonnet D; Andrieu N
Genes Chromosomes Cancer; 2005 Jan; 42(1):1-9. PubMed ID: 15390180
[TBL] [Abstract][Full Text] [Related]
7. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
Meier M; den Boer ML; Hall AG; Irving JA; Passier M; Minto L; van Wering ER; Janka-Schaub GE; Pieters R
Leukemia; 2005 Nov; 19(11):1887-95. PubMed ID: 16167060
[TBL] [Abstract][Full Text] [Related]
8. ATM gene alterations in childhood acute lymphoblastic leukemias.
Gumy Pause F; Wacker P; Maillet P; Betts D; Sappino AP
Hum Mutat; 2003 May; 21(5):554. PubMed ID: 12673804
[TBL] [Abstract][Full Text] [Related]
9. ATM mutations in cancer families.
Vorechovský I; Luo L; Lindblom A; Negrini M; Webster AD; Croce CM; Hammarström L
Cancer Res; 1996 Sep; 56(18):4130-3. PubMed ID: 8797579
[TBL] [Abstract][Full Text] [Related]
10. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic cellular characterization of an ataxia telangiectasia patient carrying a causal homozygous missense mutation.
Angèle S; Laugé A; Fernet M; Moullan N; Beauvais P; Couturier J; Stoppa-Lyonnet D; Hall J
Hum Mutat; 2003 Feb; 21(2):169-70. PubMed ID: 12552566
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
Pylkäs K; Tommiska J; Syrjäkoski K; Kere J; Gatei M; Waddell N; Allinen M; Karppinen SM; Rapakko K; Kääriäinen H; Aittomäki K; Blomqvist C; Mustonen A; Holli K; Khanna KK; Kallioniemi OP; Nevanlinna H; Winqvist R
Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
[TBL] [Abstract][Full Text] [Related]
13. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive scanning of the ATM gene with DOVAM-S.
Buzin CH; Gatti RA; Nguyen VQ; Wen CY; Mitui M; Sanal O; Chen JS; Nozari G; Mengos A; Li X; Fujimura F; Sommer SS
Hum Mutat; 2003 Feb; 21(2):123-31. PubMed ID: 12552559
[TBL] [Abstract][Full Text] [Related]
15. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
16. High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer.
Bay JO; Uhrhammer N; Pernin D; Presneau N; Tchirkov A; Vuillaume M; Laplace V; Grancho M; Verrelle P; Hall J; Bignon YJ
Hum Mutat; 1999; 14(6):485-92. PubMed ID: 10571946
[TBL] [Abstract][Full Text] [Related]
17. Functional consequences of sequence alterations in the ATM gene.
Lavin MF; Scott S; Gueven N; Kozlov S; Peng C; Chen P
DNA Repair (Amst); 2004; 3(8-9):1197-205. PubMed ID: 15279808
[TBL] [Abstract][Full Text] [Related]
18. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
[TBL] [Abstract][Full Text] [Related]
19. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
Gutiérrez-Enríquez S; Fernet M; Dörk T; Bremer M; Lauge A; Stoppa-Lyonnet D; Moullan N; Angèle S; Hall J
Genes Chromosomes Cancer; 2004 Jun; 40(2):109-19. PubMed ID: 15101044
[TBL] [Abstract][Full Text] [Related]
20. Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.
Offit K; Gilad S; Paglin S; Kolachana P; Roisman LC; Nafa K; Yeugelewitz V; Gonzales M; Robson M; McDermott D; Pierce HH; Kauff ND; Einat P; Jhanwar S; Satagopan JM; Oddoux C; Ellis N; Skaliter R; Yahalom J
Clin Cancer Res; 2002 Dec; 8(12):3813-9. PubMed ID: 12473594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
